Whole-Body Scans Can Find Trouble — and Create It
Lori Baute had never planned to seek out a full-body MRI. The 59-year-old Florida resident had heard about the scans in the same breath as celebrity wellness trends, and the pitch initially sounded extravagant rather than medically necessary. Family cancer history changed her thinking. So did the emotional burden of helping care for her mother and an adult brother with special needs. When a close friend was diagnosed with bladder cancer, Baute decided to pay for a whole-body study at a clinic near Ocala and wait for answers.
A week later, the scan produced a finding that can shake even a calm patient: lesions in the pancreas. Her gastroenterologist ordered a targeted follow-up MRI, which showed benign cysts. The episode captured the central tension around consumer-directed testing. A scan can surface an abnormality, yet the abnormality may have little or no clinical significance. From the patient’s perspective, the result still feels urgent, and the psychological cost arrives long before a diagnosis is settled.
That sequence is becoming more common as companies market whole-body imaging directly to consumers as a way to detect cancer and other illnesses early. Major medical groups, including the American Cancer Society and the American College of Radiology, do not recommend these scans for people without a very high risk of certain cancers. The reason is straightforward: broad screening in low-risk people tends to uncover incidental findings, not just dangerous disease.
Every Test Has a Price, Even When the Bill Is Not Obvious
Medical testing is often treated as a simple yes-or-no decision, but the consequences extend beyond the procedure itself. At minimum, a test costs time. It may also cost hundreds or thousands of dollars, especially when consumers buy services directly rather than through insurance. Many whole-body scans and at-home blood-testing kits are not covered by insurers, placing the financial burden on the patient from the start.
Some tests are physically mild, such as a blood draw or a stool sample. Others carry real medical risk. Computed tomography can expose patients to radiation, and NIH estimates indicate that a small fraction of people who undergo CT imaging each year will develop cancer because of that exposure. Biopsies and endoscopies are more invasive still. Pain, infection, bleeding, tears, anesthesia reactions, and other serious complications can follow even when the procedure itself is routine.
The emotional consequences can be just as immediate. Patients often wait for results with growing anxiety, then face a second wave of stress if the findings are unclear. A cardiologist at the University of California, San Francisco, described seeing patients every week who are distressed by results from studies they likely never needed in the first place. Her concern reflects a larger pattern in modern medicine: when a test is ordered without a clear question, it often creates uncertainty rather than resolution.
Incidental Findings Often Lead to a Diagnostic Cascade
A single abnormality can start a chain reaction. In medical practice, this is often called a diagnostic cascade. One scan reveals a cyst. Another test is ordered to determine whether the cyst is harmless. If the new study is inconclusive, the cycle continues. Months or years can pass in follow-up imaging, repeat consultations, and persistent worry, even when the final answer is benign.
Baute is now planning annual surveillance of her pancreas. She accepts the expense and the unease because she feels more in control with information in hand. Many patients respond the same way. They do not necessarily want more medicine; they want reassurance. The problem is that reassurance can be fragile when the pathway to it includes unpredictable downstream testing.
The most sobering examples are the ones that start with low-risk symptoms and end in injury. A case described in JAMA Internal Medicine involved a 52-year-old woman who developed chest pain after beginning an exercise program. Her evaluation suggested musculoskeletal pain and low cardiac risk, yet she still underwent cardiac testing to ease concern. The follow-up study led to an arterial tear, emergency bypass surgery, complications, and, in Redberg’s telling, a heart transplant. A test intended to reassure can become the first step toward harm when the clinical indication is weak.
The Right Questions Matter Before Any Test Is Ordered
Patients often assume that if a clinician orders a test, the answer must already be yes. It does not have to be. Before agreeing to imaging, a blood panel, or a procedure, patients should ask what the test will actually change. Will it alter treatment? Will it clarify a symptom? Will it prevent a complication? If the answer is vague, the benefit may be smaller than it appears.
A useful set of questions is simple: What will I learn? How will this help my care? Could I improve my health without it? Those questions matter because many results eventually circle back to familiar advice: improve diet, exercise regularly, stop smoking, and manage existing risk factors. In cardiology especially, the most valuable interventions are often the least glamorous ones. They do not require a scan to justify them.
The best screening tests are the ones that have already survived rigorous evidence review. When a service earns an A or B recommendation from the U.S. Preventive Services Task Force, insurers are generally required to cover it, including private plans as well as Medicaid and Medicare. That coverage reflects more than payment policy. It signals that the test has shown enough benefit, in the right population, to justify its downsides.
Consumer-marketed tests sit outside that framework far more often. They may promise early detection, but early detection is not automatically the same as better outcomes. In low-risk people, more scanning can mean more incidentalomas, more false alarms, more radiation exposure, and more procedures that were never needed. Patients considering a test should not ask only whether it can find something. They should ask whether finding it will help, whether it could hurt, and whether the evidence supports doing it at all.